drugset / Trial / NCT00229385

Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)

NCT00229385

Completed 45 enrolled Sheba Medical Center
Non-randomizedParallel-groupSingle-blindDiagnostic

Summary

Comparing schizophrenic patients with comorbid OCD and schizophrenic patients without OCD in response to Ziprasidone and in cognitive functioning as compared with OCD patients

Timeline

Start
2006-01
Primary completion
2008-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ziprasidone Small molecule 40 mg
Comparator Ziprasidone Small molecule 80 mg